{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T16:39:32Z","timestamp":1795019972736,"version":"4.10.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T00:00:00Z","timestamp":1697500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T00:00:00Z","timestamp":1697500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Key Project of Research and Development Program of Hebei Province","award":["20377753D"],"award-info":[{"award-number":["20377753D"]}]},{"name":"the Key Project of Research and Development Program of Hebei Province","award":["20377753D"],"award-info":[{"award-number":["20377753D"]}]},{"name":"the Key Project of Research and Development Program of Hebei Province","award":["20377753D"],"award-info":[{"award-number":["20377753D"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To access the efficacy of percutaneous transluminal angioplasty and arteriovenous fistula reconstruction for immature arteriovenous fistula, compare the long-term patency and post-operative complications between them.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>The medical records and Hemodialysis record sheets from 44 patients between May 2020 and January 2022 who underwent percutaneous transluminal angioplasty or arteriovenous fistula reconstruction treatment for immature autogenous arteriovenous fistula (AVF) were retrospectively reviewed. The patients were divided into two groups according to the type of surgery they received, including 25 patients in the PTA group and 19 patients in the AVF reconstruction group. Clinical outcomes were included, such as the primary and secondary patency rates following the procedure, maturation time, peak systolic velocity (PSV) of brachial artery, maximum pump-controlled blood flow at initial dialysis, and post-operative complications rates in the two groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Technical and clinical success was achieved in 100% of the 44 cases. For patients who underwent percutaneous transluminal angioplasty, the primary patency rate at 3, 6, and 9 months was 84.0%, 68.0%, 60.0%, and the secondary patency rate was 92.0%, 84.0%, 80.0%, respectively. And for patients who underwent arteriovenous fistula reconstruction, the primary patency rate at 3, 6, and 9 months was 89.5%, 73.7%, 68.4%, and the secondary patency rate was 100.0%, 94.7%, 94.7%, respectively. There were no significant differences between the two groups in terms of patency rates (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&gt;\u2009.050). In patients whose maturation was successful, the average maturation time of fistula after the PTA procedure was 19.36\u2009\u00b1\u200913.94 days, and 58.63\u2009\u00b1\u200918.95 days for the reconstruction procedure (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u2009.010). The PSV of brachial artery before and after the procedure was 87.64\u2009\u00b1\u200923.87\u00a0cm\/s and 153.20\u2009\u00b1\u200921.69\u00a0cm\/s in PTA group, for reconstruction group, the number was 86.26\u2009\u00b1\u200920.59\u00a0cm\/s and 151.26\u2009\u00b1\u200929.94\u00a0cm\/s, respectively. No statistically significant differences (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&gt;\u2009.050). The maximum pump-controlled blood flow at initial dialysis was 232.60\u2009\u00b1\u200916.72 ml\/min in PTA group, which was significantly higher than 197.11\u2009\u00b1\u200910.45 ml\/min in reconstruction group (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u2009.010). Subcutaneous hematoma, restenosis, thrombus formation, and pseudoaneurysm were major complications in PTA group. Restenosis, thrombus formation, and pseudoaneurysm were major complications in reconstruction group, with no statistically significant differences between the two groups (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&gt;\u2009.050).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>When immature AVFs require reconstruction surgery, the patency outcomes are comparable to AVFs that undergo successful management by PTA. While, when AVFs are successfully managed by PTA, they have significantly less maturation times and higher maximum pump-controlled blood flow rates at initial dialysis AVF use.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-023-03361-5","type":"journal-article","created":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T06:02:49Z","timestamp":1697522569000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The efficacy of percutaneous transluminal angioplasty and arteriovenous fistula reconstruction for immature arteriovenous fistula"],"prefix":"10.1186","volume":"24","author":[{"given":"Han","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqing","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoxing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,17]]},"reference":[{"issue":"4 Suppl 2","key":"3361_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1053\/j.ajkd.2019.12.001","volume":"75","author":"CE Lok","year":"2020","unstructured":"Lok CE, Huber TS, Lee T, Shenoy S, Yevzlin AS, Abreo K, et al. KDOQI Clinical Practice Guideline for Vascular Access: 2019 update. Am J Kidney Dis. 2020;75(4 Suppl 2):1\u2013S164. https:\/\/doi.org\/10.1053\/j.ajkd.2019.12.001.","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"3361_CR2","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.ejvs.2017.01.015","volume":"53","author":"A Kordzadeh","year":"2017","unstructured":"Kordzadeh A, Askari A, Hoff M, Smith V, Panayiotopoulos Y. The impact of patient demographics, anatomy, comorbidities, and peri-operative planning on the primary functional maturation of autogenous radiocephalic arteriovenous fistula. Eur J Vasc Endovasc Surg. 2017;53(5):726\u201332.","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"18","key":"3361_CR3","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1001\/jama.299.18.2164","volume":"299","author":"LM Dember","year":"2008","unstructured":"Dember LM, Beck GJ, Allon M, Delmez JA, Dixon BS, Greenberg A, et al. Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA. 2008;299(18):2164\u201371.","journal-title":"JAMA"},{"issue":"4","key":"3361_CR4","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1046\/j.1523-1755.2003.00210.x","volume":"64","author":"GA Beathard","year":"2003","unstructured":"Beathard GA, Arnold P, Fau - Jackson J, Jackson J, Fau - Litchfield T, Litchfield T. Aggressive treatment of early fistula failure. Kidney Int. 2003;64(4):1487\u201394.","journal-title":"Kidney Int"},{"key":"3361_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fsurg.2017.00013","volume":"4","author":"CS Bavare","year":"2017","unstructured":"Bavare CS, Street TK, Peden EK, Davies MG, Naoum JJ. Stent grafts can convert unusable Upper Arm Arteriovenous Fistulas into a functioning Hemodialysis Access: a retrospective Case Series. Front Surg. 2017;4:13.","journal-title":"Front Surg"},{"issue":"4","key":"3361_CR6","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1177\/1129729818810115","volume":"20","author":"Y Kim","year":"2019","unstructured":"Kim Y, Chung BH, Choi BS, Park CW, Yang CW, Kim YS. Outcome of endovascular salvage of immature hemodialysis arteriovenous fistulas. J Vasc Access. 2019;20(4):397\u2013403.","journal-title":"J Vasc Access"},{"issue":"3","key":"3361_CR7","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.jvs.2021.08.106","volume":"75","author":"AM Tawfik","year":"2022","unstructured":"Tawfik AM, Zidan MH, Salem A, Salem A. A randomized controlled study of early versus standard cannulation of arteriovenous grafts in hemodialysis patients. J Vasc Surg. 2022;75(3):1047\u201353.","journal-title":"J Vasc Surg"},{"issue":"5","key":"3361_CR8","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/nep.12394","volume":"20","author":"L Jia","year":"2015","unstructured":"Jia L, Wang L, Fau - Wei F, Wei F, Fau - Yu H, Yu H, Fau - Dong H, Dong H, Fau - Wang B, Wang B, Fau - Lu Z, et al. Effects of wall shear stress in venous neointimal hyperplasia of arteriovenous fistulae. Nephrology. 2015;20(5):335\u201342.","journal-title":"Nephrology"},{"issue":"12","key":"3361_CR9","doi-asserted-by":"publisher","first-page":"e0145795","DOI":"10.1371\/journal.pone.0145795","volume":"10","author":"LD Browne","year":"2015","unstructured":"Browne LD, Bashar K, Griffin P, Kavanagh EG, Walsh SR, Walsh MT. The role of Shear stress in Arteriovenous Fistula Maturation and failure: a systematic review. PLoS ONE. 2015;10(12):e0145795. https:\/\/doi.org\/10.1371\/journal.pone.0145795.","journal-title":"PLoS ONE"},{"key":"3361_CR10","doi-asserted-by":"crossref","unstructured":"Lehoux S, Castier Y, Fau - Tedgui A, Tedgui A. Molecular mechanisms of the vascular responses to haemodynamic forces. Atherosclerotic Plaque. 2021:49\u201383.","DOI":"10.1016\/B978-0-12-817195-0.00002-0"},{"issue":"1","key":"3361_CR11","doi-asserted-by":"publisher","first-page":"T67","DOI":"10.1530\/JOE-17-0009","volume":"234","author":"JJ DuPont","year":"2017","unstructured":"DuPont JJ, Jaffe IZ, 30 YEARS OF THE MINERALOCORTICOID RECEPTOR. The role of the mineralocorticoid receptor in the vasculature. J Endocrinol. 2017;234(1):T67\u2013T82.","journal-title":"J Endocrinol"},{"issue":"5","key":"3361_CR12","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s11906-014-0427-y","volume":"16","author":"JB Koenig","year":"2014","unstructured":"Koenig JB, Jaffe IZ. Direct role for smooth muscle cell mineralocorticoid receptors in vascular remodeling: novel mechanisms and clinical implications. Curr Hypertens Rep. 2014;16(5):427.","journal-title":"Curr Hypertens Rep"},{"issue":"4","key":"3361_CR13","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1096\/fj.15-271254","volume":"30","author":"M Bretschneider","year":"2016","unstructured":"Bretschneider M, Busch B, Mueller D, Nolze A, Schreier B, Gekle M, et al. Activated mineralocorticoid receptor regulates micro-RNA-29b in vascular smooth muscle cells. FASEB J. 2016;30(4):1610\u201322.","journal-title":"FASEB J"},{"issue":"11","key":"3361_CR14","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/s41684-020-00659-x","volume":"49","author":"CA-O Cai","year":"2020","unstructured":"Cai CA-O, Zhao C, Kilari S, Sharma AA-O, Singh AK, Simeon ML, et al. Experimental murine arteriovenous fistula model to study restenosis after transluminal angioplasty. Lab Anim. 2020;49(11):320\u201334.","journal-title":"Lab Anim"},{"key":"3361_CR15","doi-asserted-by":"crossref","unstructured":"de Oliveira Harduin LA-O, Guerra JB, Virgini-Magalh\u00e3es CE, da Costa FS, Vieira BR, Mello RS, et al. Oversized balloon angioplasty for endovascular maturation of arteriovenous fistulae to accelerate cannulation and to decrease the duration of catheter use. J Vasc Access. 2021. 11297298211029558.","DOI":"10.1177\/11297298211029558"},{"issue":"6","key":"3361_CR16","doi-asserted-by":"publisher","first-page":"439","DOI":"10.5301\/jva.5000271","volume":"15","author":"RH Portugaller","year":"2014","unstructured":"Portugaller RH, Kalmar Pi Fau -, Deutschmann H, Deutschmann H. The eternal tale of dialysis access vessels and restenosis: are drug-eluting balloons the solution? J Vasc Access. 2014;15(6):439\u201347.","journal-title":"J Vasc Access"},{"key":"3361_CR17","doi-asserted-by":"crossref","unstructured":"Kanchanasuttirak PA-O, Pitaksantayothin W, Saengprakai W, Kanchanabat B. Systematic review and meta-analysis: efficacy and safety of balloon angioplasty in salvaging non-matured arteriovenous fistulas. J Vasc Access. 2022. 11297298221085440.","DOI":"10.1177\/11297298221085440"},{"issue":"1","key":"3361_CR18","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1046\/j.1523-1755.2003.00740.x","volume":"63","author":"CD Miller","year":"2003","unstructured":"Miller CD, Robbin Ml Fau -, Allon M, Allon M. Gender differences in outcomes of arteriovenous fistulas in hemodialysis patients. Kidney Int. 2003;63(1):346\u201352.","journal-title":"Kidney Int"},{"issue":"2","key":"3361_CR19","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1177\/1526602820902757","volume":"27","author":"ZA-O Cao","year":"2020","unstructured":"Cao ZA-O, Li J, Zhang T, Zhao K, Zhao J, Yang Y, et al. Comparative effectiveness of drug-coated balloon vs balloon angioplasty for the treatment of Arteriovenous Fistula stenosis: a Meta-analysis. J Endovasc Ther. 2020;27(2):266\u201375.","journal-title":"J Endovasc Ther"},{"issue":"8","key":"3361_CR20","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1056\/NEJMoa1914617","volume":"383","author":"RA Lookstein","year":"2020","unstructured":"Lookstein RA, Haruguchi H, Ouriel K, Weinberg I, Lei L, Cihlar S, et al. Drug-coated balloons for dysfunctional Dialysis arteriovenous fistulas. N Engl J Med. 2020;383(8):733\u201342.","journal-title":"N Engl J Med"},{"issue":"2","key":"3361_CR21","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1053\/j.semvascsurg.2011.05.010","volume":"24","author":"A Chawla","year":"2011","unstructured":"Chawla A, DiRaimo R, Panetta T. Balloon angioplasty to facilitate autogenous arteriovenous access maturation: a new paradigm for upgrading small-caliber veins, improved function, and surveillance. Semin Vasc Surg. 2011;24(2):82\u20138. https:\/\/doi.org\/10.1053\/j.semvascsurg.2011.05.010.","journal-title":"Semin Vasc Surg"},{"issue":"5","key":"3361_CR22","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1177\/1129729819895185","volume":"21","author":"LA-O Nauta","year":"2020","unstructured":"Nauta LA-O, Voorzaat BM, Rotmans JI, Ghariq E, Urlings T, van der Bogt KEA, et al. Endovascular salvage of non-maturing autogenous arteriovenous fistulas by using angioplasty and competitive vein embolization. J Vasc Access. 2020;21(5):615\u201322.","journal-title":"J Vasc Access"},{"issue":"1","key":"3361_CR23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1053\/j.ajkd.2019.05.023","volume":"75","author":"N Karydis","year":"2020","unstructured":"Karydis N, Bevis P, Beckitt T, Silverberg D, Halak M, Calder F. An implanted blood vessel support device for arteriovenous fistulas: a Randomized Controlled Trial. Am J Kidney Dis. 2020;75(1):45\u201353.","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"3361_CR24","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.nefroe.2022.01.006","volume":"41","author":"JW Jeon","year":"2021","unstructured":"Jeon JW, Kim HR, Lee E, Lee JI, Ham YR, Na KR, et al. Effect of cilostazol on arteriovenous fistula in hemodialysis patients. Nefrolog\u00eda (English Edition). 2021;41(6):625\u201331.","journal-title":"Nefrolog\u00eda (English Edition)"},{"issue":"4","key":"3361_CR25","doi-asserted-by":"publisher","first-page":"293","DOI":"10.5301\/jva.5000561","volume":"17","author":"CF Chen","year":"2016","unstructured":"Chen CF, Yang WC, Lin CC. An update of the effect of far infrared therapy on arteriovenous access in end-stage renal disease patients. J Vasc Access. 2016;17(4):293\u20138.","journal-title":"J Vasc Access"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-023-03361-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-023-03361-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-023-03361-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T21:20:17Z","timestamp":1700515217000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-023-03361-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,17]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3361"],"URL":"https:\/\/doi.org\/10.1186\/s12882-023-03361-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2983207\/v1","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,17]]},"assertion":[{"value":"26 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures were in accordance with the principles of the Declaration of Helsinki. The project was approved by the research ethics committee of the Third Hospital of Hebei Medical University (protocol number: K2020-029-1). The need for informed consent was waived by the research ethics committee of the Third Hospital of Hebei Medical University, because of the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication\u00a0"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"304"}}